EN 
FR 
Natalia Mühlemann
Vice President, Clinical Development
Natalia Mühlemann brings over 20 years of experience in general management, clinical development, and business development in the life sciences industry to her role at Cytel.
Prior to joining Cytel in 2020, Natalia served as Global Category Head, Acute Care – Oncology – Devices at Nestle Health Sciences. She acts as an Expert Jury member for the European Commission’s Innovation Council.
Natalia holds an MD and an MBA (IMD) and professional certifications in statistics and data science. She continues to expand her education, focusing on AI/ML and CME.
Related Articles
August 1, 2024
Read More
The Role of External Data in Oncology Drug Development
December 21, 2023
Read More
Balancing priorities in therapeutics development: simulation-guided decision making
June 13, 2024
Read More
Webinar – Oncology Trials: External Control Arms and Bayesian Borrowing
January 17, 2024
Read More